RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

OSE Immunotherapeutics Net Income 2024

OSE Immunotherapeutics Net Income

13.15 M EUR

OSE Immunotherapeutics Dividend yield

Ticker

OSE.PA

ISIN

FR0012127173

WKN

A14QXP

In 2024, OSE Immunotherapeutics's profit amounted to 13.15 M EUR, a -157.18% increase from the -23 M EUR profit recorded in the previous year.

The OSE Immunotherapeutics Net Income history

YEARNET INCOME (undefined EUR)
2026e62.03
2025e52.1
2024e13.15
2023-23
2022-17.76
2021-16.85
2020-16.56
2019-4.65
20185.49
2017-10.5
201620.67
2015-5.58
2014-2.84
2013-0.25
2012-1.44

OSE Immunotherapeutics Aktienanalyse

What does OSE Immunotherapeutics do?

Ose Immunotherapeutics SA is a French biopharmaceutical company specializing in the development of cancer and autoimmune immunotherapies. The company was founded in 2008 and is based in Nantes, France. OSE Immunotherapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding OSE Immunotherapeutics's Profit Margins

The profit margins of OSE Immunotherapeutics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of OSE Immunotherapeutics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating OSE Immunotherapeutics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

OSE Immunotherapeutics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When OSE Immunotherapeutics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about OSE Immunotherapeutics Stock

How much profit has OSE Immunotherapeutics made this year?

OSE Immunotherapeutics has made 13.15 M EUR this year.

How has the profit developed compared to last year?

The profit has increased by -157.18% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does OSE Immunotherapeutics publish its earnings?

OSE Immunotherapeutics publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of OSE Immunotherapeutics?

The profits of OSE Immunotherapeutics are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of OSE Immunotherapeutics?

You can learn more about the earnings of OSE Immunotherapeutics by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does OSE Immunotherapeutics pay?

Over the past 12 months, OSE Immunotherapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OSE Immunotherapeutics is expected to pay a dividend of 0 EUR.

What is the dividend yield of OSE Immunotherapeutics?

The current dividend yield of OSE Immunotherapeutics is .

When does OSE Immunotherapeutics pay dividends?

OSE Immunotherapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of OSE Immunotherapeutics?

OSE Immunotherapeutics paid dividends every year for the past 0 years.

What is the dividend of OSE Immunotherapeutics?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is OSE Immunotherapeutics located?

OSE Immunotherapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von OSE Immunotherapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of OSE Immunotherapeutics from 5/17/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.

When did OSE Immunotherapeutics pay the last dividend?

The last dividend was paid out on 5/17/2024.

What was the dividend of OSE Immunotherapeutics in the year 2023?

In the year 2023, OSE Immunotherapeutics distributed 0 EUR as dividends.

In which currency does OSE Immunotherapeutics pay out the dividend?

The dividends of OSE Immunotherapeutics are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von OSE Immunotherapeutics

Our stock analysis for OSE Immunotherapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OSE Immunotherapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.